Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.33 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL491059 | 0.93 | MEN1 (0.62) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL8772504 | 0.93 | HTT (0.68) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL490565 | 0.93 | HTT (0.68) | MEN1KMT2AHTTTHRBMAPT | |
| Triethylene Glycol SCHEMBL25307288 | 0.91 | MEN1 (0.60) | MEN1KMT2AHTTTHRBMAPT | |
| Triethylene Glycol SCHEMBL25303227 | 0.91 | MEN1 (0.60) | MEN1KMT2AHTTTHRBMAPT | |
| Triethylene Glycol SCHEMBL25260216 | 0.89 | MEN1 (0.57) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL4421030 | 0.89 | TSHR (0.56) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL5146482 | 0.89 | MEN1 (0.61) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL4425237 | 0.88 | TSHR (0.52) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL491019 | 0.87 | MEN1 (0.53) | MEN1KMT2AHTTTHRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020216641-A1 | A HAIR WAX COMPOSITION | BEIERSDORF AG (DE) | 2020-10-29 | — | — | WO | claimed |
| CN-113164797-B | Novel cosmetic and dermatological use of Cistus polyrhachis extract | 巴斯夫美容护理法国公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-114555042-B | Novel cosmetic use of N-methylglycine for increasing the diversity of the microbial flora of the skin | 巴斯夫美容护理法国公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-109715192-B | Drug conjugates for converting neoplastic cells to non-neoplastic cells and uses thereof | 伊斯迪德股份公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117482133-A | New cosmetic or dermatological use of extract of Gentiana macrophylla Franch | 巴斯夫美容护理法国公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117379347-A | Cosmetic or dermatological use of pyracantha fortuneana extract | 巴斯夫美容护理法国公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-116831962-A | Cosmetic or dermatological use of Dendrobium officinale extract for maintaining and/or increasing skin thickness | 巴斯夫美容护理法国公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116685307-A | Cosmetic, nutritional or dermatological use of lactobacillus crispatus strains and/or compositions comprising the same | 巴斯夫美容护理法国公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-112236201-B | Use of extract of rosewood (BIXA ORELLANA) | 巴斯夫美容护理法国公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-108883055-B | Cosmetic use of African chinaberry extract | 巴斯夫美容护理法国公司 | 2023-06-02 | — | — | CN | disclosed |
| US-20040037797-A1 | Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers | BEIERSDORF AG | 2004-02-26 | — | — | US | disclosed |
| US-6620420-B2 | Cosmetic or dermatological application | BEIERSDORF AG (DE) | 2003-09-16 | — | — | US | disclosed |
| US-20030147928-A1 | Water, oil in water emulsifiers, optionally coemulsifiers, oil phase(s), polidocanol and an essential oil; saturated cloth; immediate and long-lasting effect | BEIERSDORF AG | 2003-08-07 | — | — | US | disclosed |
| US-20030091605-A1 | Use of alpha-lipoic acid for producing cosmetic or dermatological preparations for regenerating stressed skin, in particular aged skin | BEIERSDORF AG | 2003-05-15 | — | — | US | disclosed |
| US-20030012801-A1 | Active ingredient combinations of surface-active citric esters and inclusion compounds of cyclodextrins and retinoids, and cosmetic and dermatological preparations containing such mixtures | BEIERSDORF AG | 2003-01-16 | — | — | US | disclosed |
| US-20020176832-A1 | O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | CLARIANT INTERNATIONAL LTD. (CH) | 2002-11-28 | — | — | US | disclosed |
| US-20020155076-A1 | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | CLARIANT INTERNATIONAL LTD. (CH) | 2002-10-24 | — | — | US | disclosed |
| US-20020119114-A1 | Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures | BEIERSDORF AKTIENGESELLSCHAFT | 2002-08-29 | — | — | US | disclosed |
| US-6436414-B1 | Active ingredient combinations or adducts of biotin and/or biotin derivatives and cyclodextrins and use of such active ingredient combinations in cosmetic preparations | BEIERSDORF AG (DE) | 2002-08-20 | — | — | US | disclosed |
| US-20020045596-A1 | Active ingredient combinations or adducts of cyclodextrins and at least one quinone and/or at least one hydroquinone and use of such active ingredient combinations in cosmetic preparations | BEIERSDORF AG (DE) | 2002-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020045596-A1 | Active ingredient combinations or adducts of cyclodextrins and at least one quinone and/or at least one hydroquinone and use of such active ingredient combinations in cosmetic preparations | NQO1, RECQL, KEAP1 | MEN1 2565/4885KMT2A 3530/4885HTT 235/4885 |
| US-20030012801-A1 | Active ingredient combinations of surface-active citric esters and inclusion compounds of cyclodextrins and retinoids, and cosmetic and dermatological preparations containing such mixtures | ALDH1A2, GAA, GCDH | MEN1 3273/4885KMT2A 4662/4885HTT 3635/4885 |
| US-20020176832-A1 | O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | AGPAT2, PHOSPHO1, MBOAT1 | MEN1 4169/4885KMT2A 743/4885HTT 595/4885 |
| US-20020155076-A1 | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | AGPAT2, ACMSD, POLR1C | MEN1 4477/4885KMT2A 1076/4885HTT 304/4885 |
| US-20020119114-A1 | Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures | LIPA, GLA, DEGS1 | MEN1 1433/4885KMT2A 2016/4885HTT 2257/4885 |
| US-20030091605-A1 | Use of alpha-lipoic acid for producing cosmetic or dermatological preparations for regenerating stressed skin, in particular aged skin | CUTA, LIPA, LPO | MEN1 4447/4885KMT2A 4069/4885HTT 747/4885 |
| US-20030147928-A1 | Water, oil in water emulsifiers, optionally coemulsifiers, oil phase(s), polidocanol and an essential oil; saturated cloth; immediate and long-lasting effect | POLD1, POLD3, POLI | MEN1 4540/4885KMT2A 1719/4885HTT 3193/4885 |
| US-20040037797-A1 | Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers | PHOSPHO1, AGPAT2, AGPAT5 | MEN1 3181/4885KMT2A 1398/4885HTT 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.